Dyadic International (DYAI) EBT (2018 - 2026)
Dyadic International's (DYAI) quarterly EBT came in at -$1.9 million in Q1 2026, up 4.66% year-over-year from -$1.8 million in Q1 2025, and down 25.62% quarter-over-quarter from -$1.5 million in Q4 2025.
Analysis
Dyadic International (DYAI) EBT (2018 - 2026) Analysis & Trends
Dyadic International has disclosed EBT across 9 years of filings, most recently posting -$1.9 million for Q1 2026.
- In Q1 2026, EBT rose 4.66% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at -$7.1 million (down 25.93% YoY), while the FY2025 annual figure was -$7.2 million, down 26.32% from the prior year.
- EBT came in at -$1.9 million for Q1 2026 at Dyadic International, down from -$1.5 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$164116.0 in Q3 2024 to a low of -$3.3 million in Q2 2022.
- Average EBT over 5 years is -$1.9 million, with a median of -$1.9 million recorded in 2025.
- Year-over-year, EBT jumped 99.92% in 2022 and tumbled 1086.87% in 2025.
- Over 5 years, EBT stood at -$2.1 million in 2022, then climbed by 3.48% to -$2.1 million in 2023, then advanced by 26.86% to -$1.5 million in 2024, then slipped by 0.33% to -$1.5 million in 2025, then retreated by 25.62% to -$1.9 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$1.9 million in Q1 2026, -$1.5 million in Q4 2025, and -$1.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.70 Bn | 192.71 Bn | 7.24 Bn | 2.77 Bn |
| 2 | Gilead Sciences | 180.18 Bn | 177.00 Bn | 6.22 Bn | -10.25 Bn |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | 1.39 Bn |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.95 Bn | 3.93 Bn | 1.53 Bn |
| 5 | Argenx Se | 60.60 Bn | 55.42 Bn | 1.37 Bn | 542.00 Mn |
| 6 | Moderna | 53.81 Bn | 48.67 Bn | 52.00 Mn | -767.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.46 Bn | 30.15 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Biogen | 31.82 Bn | 30.54 Bn | 1.96 Bn | 132.40 Mn |
| 9 | Roivant Sciences | 29.10 Bn | 29.10 Bn | 1.16 Mn | -294.56 Mn |
| 10 | Dyadic International | 18.44 Mn | 10.48 Mn | - | -1.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -1.91 Mn |
| Dec 31, 2025 | -1.52 Mn |
| Sep 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -1.77 Mn |
| Mar 31, 2025 | -2.00 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -164,116.00 |
| Jun 30, 2024 | -1.99 Mn |
| Mar 31, 2024 | -2.06 Mn |
| Dec 31, 2023 | -2.07 Mn |
| Sep 30, 2023 | -1.61 Mn |
| Jun 30, 2023 | -2.18 Mn |
| Mar 31, 2023 | -1.95 Mn |
| Dec 31, 2022 | -2.15 Mn |
| Sep 30, 2022 | -1.81 Mn |
| Jun 30, 2022 | -3.29 Mn |
| Mar 31, 2022 | -2.74 Mn |
| Dec 31, 2021 | -4.21 Mn |
| Sep 30, 2021 | -3.32 Mn |
| Jun 30, 2021 | -3.85 Mn |